Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Paik Hospital, Busan, Republic of Korea.
Drug Metab Dispos. 2013 Apr;41(4):888-96. doi: 10.1124/dmd.112.049791. Epub 2013 Feb 1.
Human constitutive androstane receptor (hCAR, NR1I3) is a member of the orphan nuclear receptor family and regulates the transcription of many drug-metabolizing enzymes and drug transporters. Previous studies have shown that the hCAR gene produces a number of different kinds of mRNA splicing variants (SVs) in non-Asian ethnicities. In the present study, we identified 18 hCAR SVs (SV1-SV18), including four novel SVs in Korean human livers. Among the four novel SVs, SV2 showed enhanced transactivation activity when cotransfected with CYP2B6 reporter gene, whereas other SVs were nonfunctional. When profiles of major hCAR SVs were compared among 30 livers from Korean patients and 20 livers from Caucasian patients, the relative composition of each SV showed interethnic variation as well as interindividual variation. The most predominant form of hCAR SV was not wild type, but either SV4 or SV7. The summed relative amounts of SV4 and SV7 ranged from 34.5 to 57.6% in the 30 Korean livers and from 47.2 to 82.6% in the 20 Caucasian livers, suggesting large interindividual variation. The mean relative amount of nonfunctional SV9 was significantly higher in Koreans (29.8%) than in Caucasians (12.8%). The mean relative amount of novel SV2 was 9.7% in Korean livers and 3.5% in Caucasian livers. Expression profiling of hCAR proteins in human livers also supported large interindividual variation in the expressional ratio of wild-type and SVs. Our results describe for the first time the direct comparison of hCAR SV profiles between Koreans and Caucasians. The functional relevance of these interindividual and interethnic variations of hCAR mRNA expression needs to be further characterized.
人类组成型雄烷受体 (hCAR,NR1I3) 是孤儿核受体家族的成员,调节许多药物代谢酶和药物转运蛋白的转录。先前的研究表明,hCAR 基因在非亚洲种族中产生多种不同类型的 mRNA 剪接变异体 (SVs)。在本研究中,我们在韩国人肝脏中鉴定出 18 种 hCAR SV(SV1-SV18),包括四种新的 SV。在这四种新的 SV 中,SV2 与 CYP2B6 报告基因共转染时显示出增强的转录激活活性,而其他 SV 则没有功能。当比较 30 例韩国患者和 20 例高加索患者肝脏中的主要 hCAR SV 谱时,每个 SV 的相对组成在种族间和个体间均存在差异。hCAR SV 最主要的形式不是野生型,而是 SV4 或 SV7。30 例韩国肝脏中 SV4 和 SV7 的总和相对含量为 34.5%至 57.6%,20 例高加索肝脏中 SV4 和 SV7 的总和相对含量为 47.2%至 82.6%,表明个体间存在较大差异。非功能性 SV9 的平均相对含量在韩国人中明显高于高加索人(29.8%比 12.8%)。韩国肝脏中新型 SV2 的平均相对含量为 9.7%,高加索肝脏中为 3.5%。hCAR 蛋白在人肝脏中的表达谱也支持野生型和 SVs 表达比率的个体间存在较大差异。我们的研究结果首次描述了韩国人和高加索人之间 hCAR SV 谱的直接比较。需要进一步研究这些 hCAR mRNA 表达的个体间和种族间差异的功能相关性。